BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15932501)

  • 1. The immune recognition of gluten in coeliac disease.
    Ciccocioppo R; Di Sabatino A; Corazza GR
    Clin Exp Immunol; 2005 Jun; 140(3):408-16. PubMed ID: 15932501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease.
    Voisine J; Abadie V
    Front Immunol; 2021; 12():674313. PubMed ID: 34149709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
    Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
    Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells in peripheral blood after gluten challenge in coeliac disease.
    Anderson RP; van Heel DA; Tye-Din JA; Barnardo M; Salio M; Jewell DP; Hill AV
    Gut; 2005 Sep; 54(9):1217-23. PubMed ID: 16099789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.
    Nilsen EM; Lundin KE; Krajci P; Scott H; Sollid LM; Brandtzaeg P
    Gut; 1995 Dec; 37(6):766-76. PubMed ID: 8537046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease.
    Abadie V; Kim SM; Lejeune T; Palanski BA; Ernest JD; Tastet O; Voisine J; Discepolo V; Marietta EV; Hawash MBF; Ciszewski C; Bouziat R; Panigrahi K; Horwath I; Zurenski MA; Lawrence I; Dumaine A; Yotova V; Grenier JC; Murray JA; Khosla C; Barreiro LB; Jabri B
    Nature; 2020 Feb; 578(7796):600-604. PubMed ID: 32051586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease.
    Silano M; Vincentini O; De Vincenzi M
    Curr Med Chem; 2009; 16(12):1489-98. PubMed ID: 19355902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.
    Mazzarella G; Maglio M; Paparo F; Nardone G; Stefanile R; Greco L; van de Wal Y; Kooy Y; Koning F; Auricchio S; Troncone R
    Gut; 2003 Jan; 52(1):57-62. PubMed ID: 12477760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
    Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
    J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathomechanisms in celiac disease.
    Dieterich W; Esslinger B; Schuppan D
    Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coeliac disease.
    Green PH; Jabri B
    Lancet; 2003 Aug; 362(9381):383-91. PubMed ID: 12907013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coeliac disease.
    Periolo N; Cherñavsky AC
    Autoimmun Rev; 2006 Mar; 5(3):202-8. PubMed ID: 16483920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.
    Wahab WA; Šuligoj T; Ellis J; Côrtez-Real B; Ciclitira PJ
    Int J Exp Pathol; 2016 Aug; 97(4):303-309. PubMed ID: 27659035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.